Quincy, MA, United States of America

Daniel J F Chinnapen


Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel J F Chinnapen

Introduction

Daniel J F Chinnapen is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel delivery vehicles for therapeutic agents. With a total of 7 patents to his name, Chinnapen's work has the potential to impact various medical treatments.

Latest Patents

Chinnapen's latest patents include innovative formulations that utilize short chain ceramide-based lipids. One of his patents describes delivery vehicles comprising a glycosphingolipid and an agent to be delivered attached to the glycosphingolipid. This formulation allows for the effective delivery of therapeutic agents to cells or cellular compartments, enhancing their half-life compared to agents delivered alone. Another patent focuses on ceramide-like lipid-based delivery vehicles, which also facilitate the delivery of therapeutic agents. These advancements highlight Chinnapen's commitment to improving drug delivery systems.

Career Highlights

Throughout his career, Chinnapen has worked with reputable organizations, including Children's Medical Center Corporation and Children's Medical Corporation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Chinnapen has had the opportunity to work alongside esteemed colleagues such as Wayne I Lencer and Randy Mrsny. These collaborations have further enriched his research and innovation efforts.

Conclusion

Daniel J F Chinnapen's contributions to the field of biomedical research through his innovative patents and collaborations demonstrate his dedication to advancing medical science. His work continues to pave the way for improved therapeutic delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…